Intensity Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · Shelton, CT, United States
- PrincipalsJoseph TalamoChief Financial OfficerLewis H BenderPresident and CEOand 1 more
- CompanyIntensity Therapeutics, Inc.Shelton, CT, United States
- Phone line+1 (203) 221-7381General business
Intensity Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker INTS) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Chief executive
Lewis H BenderPresident and CEO
Finance
Joseph TalamoChief Financial Officer
Everyone else on file (1)
John M WesolowskiPrincipal Accounting Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Lewis H Bender — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Joseph Talamo — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗John M Wesolowski — Principal Accounting Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Entera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capability